Financhill
Back

Alexandria Real Estate Equities Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Buy
55

ARE
Alexandria Real Estate Equities

Last Price:
118.07
Seasonality Move:
4.55%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.45
Seasonality Move:
3.65%
Buy
55
Alexandria Real Estate Equities (ARE) is a Buy

Is Alexandria Real Estate Equities a Buy, Sell or Hold?

  • The current Alexandria Real Estate Equities [ARE] share price is $116.56. The Score for ARE is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • ARE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.60. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ARE Stock Price Chart

What is Alexandria Real Estate Equities's stock price today?

  • The Alexandria Real Estate Equities share price today is $116.56
    The current trend is relatively stagnant and ARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

ARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.13 Sell
Relative Strength Index (14 RSI): 47.46 Sell
Chaikin Money Flow: 1624826 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (114.57 - 120.99) Sell
Bollinger Bands (100): (116.62 - 124.6) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.73 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 722527 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.99 - 42.29) Sell
Bollinger Bands (100): (41.03 - 48.83) Sell

ARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 115.68 Buy
20-day SMA: 116.31 Buy
50-day SMA: 118.53 Sell
200-day SMA: 115.86 Buy
8-day EMA: 115.89 Buy
20-day EMA: 116.77 Sell
50-day EMA: 118.58 Sell
200-day EMA: 120.01 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.38 Sell
20-day SMA: 40.41 Sell
50-day SMA: 41.94 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.76 Sell
20-day EMA: 40.54 Sell
50-day EMA: 42.03 Sell
200-day EMA: 43.46 Sell

Alexandria Real Estate Equities Earnings Growth & ARE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.24 per share, an increase next quarter of $0.02 per share, a decrease this year of $6.40 per share, and an increase next year of $0.12 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

Alexandria Real Estate Equities Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):